✦ LIBER ✦

Predictors of Long-Term Survival in Patients with Lung Cancer Included in the Randomized Spanish Lung Cancer Group 0008 Phase II Trial Using Concomitant Chemoradiation with Docetaxel and Carboplatin plus Induction or Consolidation Chemotherapy

✍ Scribed by Pilar Garrido; Rafael Rosell; Bartomeu Massutí; Felipe Cardenal; Vicente Alberola; Manuel Dómine; Inmaculada Maeztu; Alfredo Ramos; Antonio Arellano

Book ID: 119935611
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 130 KB
Volume: 10
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2009.n.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II trial of non-platinu

Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study

✍ Garrido, Pilar; Rosell, Rafael; Arellano, Antonio; Andreu, Francisco; Dómine, Ma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 853 KB

6500 ORAL Randomized phase II trial usin

6500 ORAL Randomized phase II trial using concomitant chemoradiation plus induction (I) or consolidation (C) chemotherapy (CT) for unresectable stage III non-small cell lung cancer (NSCLC) patients (pts). Mature results of the SLCG 0008 study

✍ Garrido, P.; Massuti, B.; Jimenez, A.; Samper, P.; Mesia, C.; Rodriguez, N.; Lia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

PD-042 Induction (I) or consolidation (C

PD-042 Induction (I) or consolidation (C) chemotherapy withdocetaxel (D) and gemcitabine (G) plus concomitant chemoradiotherapy (CT/TRT) with docetaxel and carboplatin (Cb) for unresectable stage III non-small cell lung cancer (NSCLC) patients (p). Initial report of the randomized phase II trial SLCG 0008

✍ Garrido, P.; Resell, R.; Arellano, A.; Ramos, A.; Massuti, T.; Andreu, J.; Carde 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB